Profiel
John Womelsdorf worked as Vice President-Business Development at Optimer Pharmaceuticals LLC and Cyclacel Pharmaceuticals, Inc. He holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree, and a doctorate from Stevens Institute of Technology.
Eerdere bekende functies van John Womelsdorf
| Bedrijven | Functie | Einde |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 17-04-2009 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | - |
Opleiding van John Womelsdorf
| Stevens Institute of Technology | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
